Starzl, T E <br/><br/>
FK 506 for liver, kidney, and pancreas transplantation.  [electronic resource] 

 -  Lancet (London, England)  Oct 1989 
 - 1000-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0140-6736 
<br/><br/><label>Standard No.: </label>10.1016/s0140-6736(89)91014-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Anti-Bacterial Agents--administration & dosage<br/>Biopsy<br/>Clinical Trials as Topic<br/>Drug Administration Schedule<br/>Drug Evaluation<br/>Drug Therapy, Combination<br/>Female<br/>Graft Rejection--drug effects<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Infusions, Intravenous<br/>Kidney Transplantation--immunology<br/>Liver--pathology<br/>Liver Transplantation--immunology<br/>Male<br/>Methylprednisolone--administration & dosage<br/>Middle Aged<br/>Pancreas Transplantation--immunology<br/>Prednisone--administration & dosage<br/>Reoperation<br/>Risk Factors<br/>Tacrolimus